| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9833 | 
      | Human Intestinal Absorption | HIA+ | 0.7183 | 
      | Caco-2 Permeability | Caco2- | 0.8232 | 
      | P-glycoprotein Substrate | Substrate | 0.7092 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8020 | 
                                                     | Non-inhibitor | 0.9317 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9464 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7507 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8384 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8989 | 
      | CYP450 3A4 Substrate | Substrate | 0.6228 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8019 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9950 | 
                                                                    | Non-inhibitor | 0.7584 | 
      | AMES Toxicity | Non AMES toxic | 0.8374 | 
      | Carcinogens | Non-carcinogens | 0.8692 | 
      | Fish Toxicity | High FHMT | 0.9902 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9369 | 
      | Honey Bee Toxicity | Low HBT | 0.6537 | 
      | Biodegradation | Not ready biodegradable | 0.9955 | 
      | Acute Oral Toxicity | III | 0.8019 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6904 |